Axikin Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.axikin.com
A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma
- First Posted Date
- 2013-07-01
- Last Posted Date
- 2016-02-05
- Lead Sponsor
- Axikin Pharmaceuticals, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT01890161
- Locations
- 🇨🇦
Vancouver General Hospital, The Lung Centre, Vancouver, British Columbia, Canada
🇨🇦McMaster University, Hamilton, Ontario, Canada
🇨🇦IUCPQ, Institut de cardiologie et de pneumologie de l'Hôpital Laval, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath